Samrat Pharmachem Ltd. benchmarking: Performance to industry peers

Financial

	Samrat Pharmachem	JFL Life Sciences	Kabra Drugs
Operational Metrics
Financials
5 yr Average ROE	18.86 %	12.26 %	36.01 %
5yr average Equity Multiplier	1.83	2.68	-0.87
5yr Average Asset Turnover Ratio	2.61	0.93	0.0
5yr Avg Net Profit Margin	3.87 %	5.75 %	0.0
Price to Book	0.89	1.45	2.42
P/E	0.0	12.72	14.69
5yr Avg Cash Conversion Cycle	58.79 Days	138.58 Days	0.0
Inventory Days	28.98 Days	96.42 Days	0.0
Days Receivable	80.32 Days	135.23 Days	0.0
Days Payable	46.76 Days	103.44 Days	0.0
5yr Average Interest Coverage Ratio	16.47	4.03	-1068.45
5yr Avg ROCE	27.43 %	17.72 %	21.53 %
5yr Avg Operating Profit Margin	5.58 %	10.31 %	0.0
5 yr average Debt to Equity	0.21	0.9	-1.45
5yr CAGR Net Profit	5.93 %	50.43 %	43.36 %
5yr Average Return on Assets	10.3 %	5.01 %	-21.34 %
Shareholdings
Promoter Holding	49.09 %	67.47 %	0.0
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.45 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Samrat Pharmachem	JFL Life Sciences	Kabra Drugs
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical Products 0 Others 100	Product Wise Break-Up Pharmaceuticals 100.0	Product Wise Break-Up Pharmaceutical Products 0 Others 100